India gets Ozempic as Novo Nordisk rolls out weekly diabetes jab known worldwide for slimming effects
A photo illustration of a man with Ozempic injection pen. Pic/Getty images
Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as 0.25 mg, 0.5 mg and 1 mg in ‘FlexTouch Pen’ - an easy-to-use, once-weekly pen device, at a starting cost of Rs 2200 per week, the company announced here.
Novo Nordisk India Managing Director, Vikrant Shrotriya, said through Ozempic, the company is looking to provide patients with an innovative and accessible therapy for the treatment of type 2 diabetes while also offering meaningful weight management and long-term heart and kidney protection.
“We are very judicious in terms of pricing in India. It really remains very competitive, internally and externally as well, to offer at a price like this,” Shrotriya told PTI when asked how Ozempic pricing in India compares with other global markets.
“I would say that it still comes under the affordability zone of the pricing, which is at a range for countries similar to India.” Novo Nordisk is marketing Ozempic purely as a treatment for type II diabetes in India, he added. “We applied for type 2 diabetes. We got (approval from the drug regulator in India) for it,” he noted.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
